Home> Products> safe medication use guidelines

{ "products": [ { "_id": "68c29ba02244c906e7790e2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TELAVINCE 300", "description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.", "price": 1480.0, "discountamount": 444.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2179, "imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png", "tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-11T09:51:28.508Z", "updatedon": "2025-09-11T09:51:28.508Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/telavince-300/2179", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a4a65aea4ed7f1f8cd234b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Methotrexate (15mg)", "description": "METROTREX 15 contains Methotrexate 15mg, a potent medication used in the treatment of autoimmune diseases and certain types of cancer. As an antifolate drug, it inhibits cell division, making it effective for managing conditions like rheumatoid arthritis, psoriasis, and leukemia.\n\n \nKey Benefits of METROTREX 15:\n \n\nMETROTREX 15 provides several therapeutic benefits, including:\n\nTreatment of Rheumatoid Arthritis: Helps reduce joint inflammation and pain by suppressing immune responses.\n\nManagement of Psoriasis: Slows down excessive skin cell production, alleviating symptoms of psoriasis.\n\nCancer Therapy: Used in chemotherapy for conditions like leukemia, breast cancer, and lymphoma by inhibiting cancer cell growth.\n\nTreatment of Crohn’s Disease: Helps in managing severe cases of inflammatory bowel disease.\n\n \nHow Does METROTREX 15 Work?\n \n\nMethotrexate 15mg works by inhibiting dihydrofolate reductase (DHFR), an enzyme essential for DNA synthesis and cell division. By blocking this enzyme, METROTREX 15 prevents the rapid multiplication of abnormal cells, making it effective in autoimmune diseases and cancer treatment.\n\n \nDirections for Use of METROTREX 15:\n \n\nTo ensure the safe and effective use of METROTREX 15, follow these guidelines:\n\nTake METROTREX 15 exactly as prescribed by your doctor.\n\nIt is usually taken once a week for autoimmune conditions and as per the oncologist’s recommendation for cancer therapy.\n\nSwallow the tablet whole with water, preferably after meals to reduce stomach irritation.\n\nRegular monitoring of blood tests is necessary to assess the drug’s effects.\n\n \nSide Effects of METROTREX 15:\n \n\nWhile METROTREX 15 is effective, it may cause some side effects, including:\n\nCommon Side Effects:\n\nNausea and vomiting\n\nFatigue\n\nMouth ulcers\n\nHair loss\n\nDizziness\n\nSerious Side Effects:\n\nLiver toxicity\n\nKidney dysfunction\n\nSuppressed bone marrow function leading to low blood cell counts\n\nIncreased risk of infections\n\nLung inflammation\n\nSeek immediate medical attention if you experience severe side effects.", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "metrotrex 15", "metrotrex 15 follow", "autoimmune conditions", "medical attention", "side effects", "blood tests", "water preferably", "oncologists recommendation", "rapid multiplication", "cell division", "dna synthesis", "enzyme essential", "antifolate drug", "autoimmune diseases", "potent medication", "methotrexate 15mg", "methotrexate 15mgmetrotrex 15", "managing conditions", "therapeutic benefits", "psoriasis slows", "cancer treatment directions", "psoriasis cancer therapy", "managing severe cases", "leukemia key benefits", "cancer therapy swallow", "leukemia breast cancer", "rheumatoid arthritis psoriasis", "abnormal cells making", "inflammatory bowel disease", "crohns disease helps" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2051, "imageuri": "https://productimages.withfloats.com/actual/67a4a66d145c10370e023f04.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a4a66d145c10370e023f04.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-06T12:08:58.343Z", "updatedon": "2025-02-06T12:08:58.343Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/methotrexate-15mg-/2051", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METROTREX 15 ", "category": "", "tags": [ "Methotrexate 15 mg uses", "Methotrexate 15 mg Tablet price", "Methotrexate 15 mg Uses in Hindi", "Folitrax 15 mg tablet price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e6fa253fc1c22985081c8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SLIM BOOST CTSTAT 120 ", "description": "SLIM BOOST CTSTAT 120 \nCetilistat (120mg)\nIntroduction\nSLIM BOOST CTSTAT 120 is an advanced weight management medication containing Cetilistat (120mg), a potent oral lipase inhibitor aimed at aiding weight reduction in individuals struggling with obesity. By preventing the digestion and absorption of dietary fats, Cetilistat helps decrease caloric intake, facilitating weight loss when combined with a reduced-calorie diet and appropriate physical activity.\n\nComposition\n\nCetilistat (120mg): A lipase inhibitor that specifically targets and inhibits gastrointestinal lipases, crucial enzymes for the digestion of fats.\nMechanism of Action\nCetilistat works by inhibiting the action of pancreatic lipase, an enzyme necessary for the breakdown of triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids and monoglycerides. Instead, undigested triglycerides are excreted in the feces, leading to reduced calorie absorption and aiding weight loss.\n\nIndications\nSLIM BOOST CTSTAT 120 is indicated for:\n\nObesity Management: To assist in weight reduction for obese patients with a body mass index (BMI) of 30 or higher.\nWeight Loss for Overweight Patients: With a BMI of 27 or higher who also have risk factors such as diabetes, hypertension, or dyslipidemia.\nDosage and Administration\n\nRecommended Dosage: The typical dosage is 120mg taken three times daily with or up to one hour after meals containing fat.\nAdministration: It should be taken with water and alongside a nutritionally balanced, reduced-calorie diet that contains approximately 30% of calories from fat. Following dietary recommendations is crucial to minimize gastrointestinal side effects and enhance weight loss efficacy.\nSide Effects\nCommon side effects may include:\n\nGastrointestinal issues such as oily spotting, flatulence with discharge, fecal urgency, fatty/oily stool, increased defecation, and fecal incontinence.\nAbdominal pain or discomfort\nDiarrhea\nNausea\nThese side effects are typically related to the drug's mechanism of action and can often be managed by adhering to the recommended dietary guidelines.\n\nPrecautions\n\nChronic Malabsorption Syndrome: Cetilistat should not be used in patients with chronic malabsorption syndrome.\nCholestasis: It is contraindicated in patients with cholestasis (a condition where bile flow from the liver is blocked).\nFat-Soluble Vitamins: Cetilistat may impair the absorption of fat-soluble vitamins (A, D, E, and K). It is recommended to take a multivitamin supplement at least 2 hours before or after taking Cetilistat.\nDrug Interactions\n\nCyclosporine: Concomitant use may decrease cyclosporine levels; it should be administered 2 hours before or after Cetilistat.\nWarfarin: Close monitoring of anticoagulant effects is necessary when co-administered, as Cetilistat may affect vitamin K absorption.\nFat-Soluble Vitamins and Supplements: Ensure adequate intake of vitamins A, D, E, and K by taking a multivitamin supplement.\nConclusion\nSLIM BOOST CTSTAT 120, with its active ingredient Cetilistat, provides an effective solution for managing obesity and supporting weight loss efforts. By inhibiting fat absorption, it helps reduce caloric intake, contributing to weight loss when combined with a balanced, reduced-calorie diet and regular physical activity. It is essential to use this medication under the guidance of a healthcare professional to ensure safe and effective weight loss while minimizing potential side effects and nutrient deficiencies. Adhering to dietary recommendations and monitoring for any adverse effects will help achieve the best outcomes with SLIM BOOST CTSTAT 120.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 580.0, "discountamount": 174.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "bile flow", "vitamins A", "dietary fats", "risk factors", "best outcomes", "fecal urgency", "oily spotting", "fat absorption", "obese patients", "typical dosage", "Abdominal pain", "caloric intake", "adequate intake", "Concomitant use", "crucial enzymes", "adverse effects", "lipase activity", "body mass index", "Close monitoring", "fatty/oily stool", "weight reduction", "Drug Interactions", "active ingredient", "pancreatic lipase", "SLIM BOOST CTSTAT", "Recommended Dosage", "dietary guidelines", "fecal incontinence", "Obesity Management", "effective solution", "cyclosporine levels", "Overweight Patients", "weight loss efforts", "Common side effects", "Fat-Soluble Vitamins", "weight loss efficacy", "vitamin K absorption", "nutrient deficiencies", "anticoagulant effects", "effective weight loss", "potential side effects", "healthcare professional", "multivitamin supplement", "dietary recommendations", "Gastrointestinal issues", "undigested triglycerides", "gastrointestinal lipases", "regular physical activity", "reduced calorie absorption", "absorbable free fatty acids", "potent oral lipase inhibitor", "gastrointestinal side effects", "appropriate physical activity", "balanced, reduced-calorie diet", "Chronic Malabsorption Syndrome", "advanced weight management medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1932, "imageuri": "https://productimages.withfloats.com/actual/68316fd9ab217a50d26b6b09.png", "tileimageuri": "https://productimages.withfloats.com/tile/68316fd9ab217a50d26b6b09.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:25:22.65Z", "updatedon": "2025-05-24T07:05:59.696Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//slim-boost-ctstat-120-/1932", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cetilistat (120mg)", "category": "GENERAL RANGE", "tags": [ "Cetilistat vs orlistat", "Cetilistat dosage", "Cetilistat side effects", "Cetilistat 120 mg side effects", "Cetilistat 120 mg brands in india", "Cetilistat 120 mg Uses in Hindi", "Cetilistat Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e6cdd5c559a0c24bb221a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SLIM BOOST CTSTAT 60 ", "description": "SLIM BOOST CTSTAT 60 \nCetilistat (60mg)\nIntroduction\nSLIM BOOST CTSTAT 60 is a weight management medication containing Cetilistat (60mg), an oral lipase inhibitor designed to assist in weight reduction in individuals with obesity. By inhibiting the digestion and absorption of dietary fats, Cetilistat helps reduce caloric intake, promoting weight loss when used in conjunction with a reduced-calorie diet and appropriate physical activity.\n\nComposition\n\nCetilistat (60mg): A novel lipase inhibitor that targets gastrointestinal lipases, crucial enzymes for fat digestion.\nMechanism of Action\nCetilistat works by inhibiting pancreatic lipase, an enzyme necessary for the breakdown of triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids and monoglycerides. Instead, undigested triglycerides are excreted, reducing the overall caloric intake and aiding weight loss.\n\nIndications\nSLIM BOOST CTSTAT 60 is indicated for:\n\nObesity Management: To assist in weight reduction for obese patients with a body mass index (BMI) of 30 or higher.\nWeight Loss for Overweight Patients: With a BMI of 27 or higher who also have risk factors such as diabetes, hypertension, or dyslipidemia.\nDosage and Administration\n\nRecommended Dosage: The typical dosage is 60mg taken three times daily with or up to one hour after meals containing fat.\nAdministration: It should be taken with water and in conjunction with a nutritionally balanced, reduced-calorie diet that contains approximately 30% of calories from fat. Adherence to dietary recommendations is crucial to minimize gastrointestinal side effects and enhance weight loss efficacy.\nSide Effects\nCommon side effects may include:\n\nGastrointestinal issues such as oily spotting, flatulence with discharge, fecal urgency, fatty/oily stool, increased defecation, and fecal incontinence.\nAbdominal pain or discomfort\nDiarrhea\nNausea\nThese side effects are typically related to the drug's mechanism of action and can often be managed by adhering to the recommended dietary guidelines.\n\nPrecautions\n\nChronic Malabsorption Syndrome: Cetilistat should not be used in patients with chronic malabsorption syndrome.\nCholestasis: It is contraindicated in patients with cholestasis (a condition where bile flow from the liver is blocked).\nFat-Soluble Vitamins: Cetilistat may impair the absorption of fat-soluble vitamins (A, D, E, and K). It is recommended to take a multivitamin supplement at least 2 hours before or after taking Cetilistat.\nDrug Interactions\n\nCyclosporine: Concomitant use may decrease cyclosporine levels; it should be administered 2 hours before or after Cetilistat.\nWarfarin: Close monitoring of anticoagulant effects is necessary when co-administered, as Cetilistat may affect vitamin K absorption.\nFat-Soluble Vitamins and Supplements: Ensure adequate intake of vitamins A, D, E, and K by taking a multivitamin supplement.\nConclusion\nSLIM BOOST CTSTAT 60, with its active ingredient Cetilistat, offers an effective solution for weight management in obese and overweight individuals. By inhibiting fat absorption, it helps reduce caloric intake, contributing to weight loss when combined with a balanced, reduced-calorie diet and regular physical activity. It is essential to use this medication under the guidance of a healthcare professional to ensure safe and effective weight loss while minimizing potential side effects and nutrient deficiencies. Always adhere to dietary recommendations and monitor for any adverse effects to achieve the best outcomes with SLIM BOOST CTSTAT 60.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 450.0, "discountamount": 135.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "bile flow", "vitamins A", "risk factors", "dietary fats", "fat digestion", "best outcomes", "fecal urgency", "oily spotting", "obese patients", "fat absorption", "typical dosage", "Abdominal pain", "Concomitant use", "crucial enzymes", "adequate intake", "adverse effects", "lipase activity", "body mass index", "Close monitoring", "fatty/oily stool", "weight reduction", "Drug Interactions", "active ingredient", "pancreatic lipase", "SLIM BOOST CTSTAT", "Recommended Dosage", "Obesity Management", "dietary guidelines", "fecal incontinence", "effective solution", "cyclosporine levels", "Overweight Patients", "Common side effects", "Fat-Soluble Vitamins", "weight loss efficacy", "vitamin K absorption", "nutrient deficiencies", "anticoagulant effects", "effective weight loss", "oral lipase inhibitor", "overweight individuals", "overall caloric intake", "potential side effects", "novel lipase inhibitor", "healthcare professional", "multivitamin supplement", "dietary recommendations", "Gastrointestinal issues", "undigested triglycerides", "gastrointestinal lipases", "regular physical activity", "absorbable free fatty acids", "weight management medication", "gastrointestinal side effects", "appropriate physical activity", "balanced, reduced-calorie diet", "Chronic Malabsorption Syndrome" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1931, "imageuri": "https://productimages.withfloats.com/actual/668e6cdfa916e42e88302495.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e6cdfa916e42e88302495.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:13:33.226Z", "updatedon": "2024-07-10T11:13:33.226Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/slim-boost-ctstat-60-/1931", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SLIM BOOST CTSTAT 60 ", "category": "GENERAL RANGE", "tags": [ "Cetilistat vs orlistat", "Cetilistat 120 mg Uses in Hindi", "", "Cetilistat dosage", "Cetilistat Tablets", "Cetilistat Brand name", "Cetilistat side effects", "Cetilistat 120 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665da07fccd5ce1a1075551d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "HYDROZOLIN ISDN ", "description": "HYDROZOLIN ISDN \nIsosorbide Dinitrate (20mg), Hydralazine (37.5mg)\nHYDROZOLIN ISDN is a combination medication containing Isosorbide Dinitrate (20mg) and Hydralazine (37.5mg), used for the treatment of certain heart conditions.\n\nComponents:\n\nIsosorbide Dinitrate (ISDN): A vasodilator that relaxes and widens blood vessels, improving blood flow and reducing the workload on the heart.\nHydralazine: Another vasodilator that works by relaxing blood vessels, leading to decreased blood pressure and improved blood flow.\nUses:\n\nManagement of heart failure, a condition where the heart is unable to pump blood effectively.\nTreatment of hypertension (high blood pressure) in certain individuals.\nDosage:\nThe recommended dose of HYDROZOLIN ISDN may vary depending on the individual's condition and response to treatment. It's important to follow the dosage instructions provided by a healthcare professional.\n\nSide Effects:\nCommon side effects of HYDROZOLIN ISDN may include headache, dizziness, flushing, rapid heartbeat, and nausea. Serious side effects such as allergic reactions or low blood pressure may occur in some individuals. Consult a healthcare provider for a complete list of side effects.\n\nPrecautions:\n\nInform your healthcare provider about any medical conditions, medications, or supplements you are taking before starting HYDROZOLIN ISDN.\nMonitor blood pressure regularly while taking this medication.\nAvoid sudden discontinuation of HYDROZOLIN ISDN without medical supervision.\nConclusion:\nHYDROZOLIN ISDN, combining Isosorbide Dinitrate and Hydralazine, is used for the management of heart failure and hypertension. It should be used as directed by a healthcare professional, with regular monitoring for side effects and therapeutic response.\nSteris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. Based in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, underscoring its commitment to quality and safety. Sterispharma is dedicated to providing high-quality drugs at affordable prices across India, strictly adhering to WHO guidelines. Sterispharma offers the convenience of an online pharmacy, enabling customers to easily purchase medicines and benefit from home delivery. The company's mission is to supply a wide array of healthcare products to meet the diverse needs of the medical community. Whether it's advanced treatments, medications for rare conditions, or essential health necessities, Sterispharma strives to serve the broad demands of the healthcare industry. If you need medicine then you can order it on these two websites sterisonline and sterispharma Order Now Sterispharma's extensive product lineup includes treatments for various health areas such as Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \nhttps://www.sterisonline.com/product/hydrozolin-isdn-133305\n\n", "price": 139.0, "discountamount": 42.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GMP", "Call", "Uses", "Email", "group", "India", "Asthma", "nausea", "safety", "Urology", "company", "mission", "workload", "Oncology", "February", "flushing", "headache", "Diabetes", "WhatsApp", "customers", "medicines", "dizziness", "Nephrology", "Cardiology", "Components", "wide array", "commitment", "Pediatrics", "Management", "Conclusion", "blood flow", "Gynecology", "Dermatology", "information", "Hydralazine", "vasodilator", "supplements", "Dental Care", "medications", "Antibiotics", "Orthopedics", "Precautions", "convenience", "Navi Mumbai", "individuals", "hypertension", "two websites", "sterisonline", "diverse needs", "heart failure", "broad demands", "home delivery", "complete list", "Endocrinology", "blood vessels", "certifications", "WHO guidelines", "HYDROZOLIN ISDN", "rare conditions", "online pharmacy", "rapid heartbeat", "hydrozolin-isdn", "Gastroenterology", "General Medicine", "heart conditions", "Nasal Conditions", "recommended dose", "medical community", "affordable prices", "medical conditions", "low blood pressure", "Respiratory Issues", "high-quality drugs", "regular monitoring", "allergic reactions", "Common side effects", "high blood pressure", "healthcare provider", "healthcare products", "healthcare industry", "advanced treatments", "medical supervision", "dosage instructions", "sterispharma Order", "Isosorbide Dinitrate", "expert professionals", "Serious side effects", "therapeutic response", "various health areas", "sudden discontinuation", "combination medication", "pharmaceutical industry", "healthcare professional", "extensive product lineup", "Steris Healthcare Pvt Ltd", "essential health necessities" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1232, "imageuri": "https://productimages.withfloats.com/actual/665da0a0947ffd864eba7c72.png", "tileimageuri": "https://productimages.withfloats.com/tile/665da0a0947ffd864eba7c72.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-03T10:52:47.172Z", "updatedon": "2024-06-03T10:52:47.172Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/hydrozolin-isdn-/1232", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Isosorbide Dinitrate (20mg), Hydralazine (37.5mg)", "category": "CARDIOLOGYRANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "662f6615daf7a411d0a910a5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RAPIDKOF LINCTUS SUSPENSION ", "description": "RAPIDKOF LINCTUS SUSPENSION \nLevocloperastine Fendizoate Oral Suspension\nRapidkof Linctus Suspension is an oral suspension containing Levocloperastine Fendizoate. This medication is commonly used to alleviate cough symptoms. Levocloperastine Fendizoate works by suppressing cough reflexes, providing relief from dry and irritating coughs. Rapidkof Linctus Suspension is easy to administer and suitable for adults and children. It is important to follow the recommended dosage and usage guidelines provided by healthcare professionals for optimal effectiveness and safety.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n", "price": 175.0, "discountamount": 100.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "dry", "relief", "adults", "dosage", "safety", "children", "medication", "cough symptoms", "cough reflexes", "usage guidelines", "irritating coughs", "optimal effectiveness", "healthcare professionals", "RAPIDKOF LINCTUS SUSPENSION", "Levocloperastine Fendizoate Oral Suspension" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 808, "imageuri": "https://productimages.withfloats.com/actual/662f66182c1b2858508cbf02.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/662f66182c1b2858508cbf02.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-29T09:19:17.567Z", "updatedon": "2024-06-12T12:57:34.964Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rapidkof-linctus-suspension-/808", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Levocloperastine Fendizoate Oral Suspension", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-09-25T10:46:50.098Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68beb3498d01aa56733d32d9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rivastigmine capsules IP 3 mg", "description": "PYRITIGMIN RIVA 3\nRivastigmine Capsules IP 3 mg\nPyritigmin Riva 3 is a trusted and effective formulation containing Rivastigmine Capsules IP 3 mg, designed to support patients suffering from cognitive decline associated with Alzheimer’s disease and Parkinson’s disease dementia. Manufactured with precision and care by Steris Healthcare, this medication belongs to the class of cholinesterase inhibitors and works by improving communication between nerve cells in the brain.\nAlzheimer’s disease and Parkinson’s disease dementia are progressive neurological conditions that impair memory, thinking, and overall cognitive function. While there is currently no cure, Pyritigmin Riva 3 offers symptomatic relief by enhancing mental clarity, reducing memory loss, and helping patients maintain daily functional independence for longer.\nComposition\nActive Ingredient: Rivastigmine Capsules IP 3 mg\nBrand Name: Pyritigmin Riva 3\nFormulation: Hard gelatin capsules\nUses of Rivastigmine Capsules (Pyritigmin Riva 3)\nAlzheimer’s Disease: Helps reduce memory loss, confusion, and cognitive decline.\nParkinson’s Disease Dementia: Improves focus, alertness, and reduces confusion.\nMild to Moderate Dementia: Enhances daily living activities and maintains patient independence.\nCognitive Function Support: Improves learning ability and attention span.\nHow Does Pyritigmin Riva 3 Work?\nRivastigmine, the main component of Pyritigmin Riva 3, works as a cholinesterase inhibitor. It blocks the enzymes acetylcholinesterase and butyrylcholinesterase, which break down acetylcholine—a neurotransmitter essential for memory and learning. By preventing its breakdown, Rivastigmine increases acetylcholine levels in the brain, thereby improving nerve cell communication.\nThis mechanism slows the worsening of symptoms, giving patients more time to maintain their mental functions and quality of life.\nDosage and Administration\nTypical Dose: One capsule of Pyritigmin Riva 3 (Rivastigmine 3 mg) twice daily with food, or as directed by your doctor.\nTitration: The dose may be adjusted gradually depending on tolerance and effectiveness.\nAdministration:\nSwallow the capsule whole with a glass of water.\nDo not crush or chew.\nTake at the same time each day to maintain stable drug levels.\nKey Benefits of Pyritigmin Riva 3\nImproves Memory Retention – Enhances recall ability and reduces forgetfulness.\nSlows Symptom Progression – Delays worsening of dementia symptoms.\nSupports Daily Activities – Helps patients maintain independence in dressing, eating, and communication.\nDual Action in Dementia – Effective in both Alzheimer’s disease and Parkinson’s-related dementia.\nWell-Tolerated Formulation – Designed for safe, effective long-term use.\nPossible Side Effects\nLike all medications, Pyritigmin Riva 3 may cause side effects in some individuals.\nCommon Side Effects:\nNausea\nVomiting\nLoss of appetite\nDizziness\nStomach pain\nDiarrhea\nSerious Side Effects (rare):\nSevere weight loss\nFainting or irregular heartbeat\nSeizures\nSevere allergic reaction (rash, swelling, breathing difficulty)\nPrecautions and Warnings\nInform your doctor if you have a history of heart problems, asthma, peptic ulcers, or seizures.\nUse with caution in patients with low body weight.\nAvoid alcohol, as it may worsen side effects.\nNot recommended during pregnancy or breastfeeding unless prescribed by a doctor.\nShould be used only under strict medical supervision.\nDrug Interactions\nRivastigmine may interact with:\nOther cholinergic drugs (donepezil, galantamine) – risk of side effects increases.\nAnticholinergic drugs – reduced effectiveness.\nBeta-blockers – may increase risk of slow heart rate.\nNSAIDs (like ibuprofen, aspirin) – may increase stomach irritation risk.\nAlways inform your healthcare provider about all medications you are taking.\nWhy Choose Steris Healthcare for Pyritigmin Riva 3?\nSteris Healthcare is a leading pharmaceutical company recognized for its commitment to quality, safety, and affordability. By choosing Pyritigmin Riva 3, patients and caregivers can trust:\nWHO-GMP Certified Manufacturing – Assuring international quality standards.\nStringent Quality Control – Every batch is tested for safety and efficacy.\nAffordable Pricing – Making dementia care accessible for all patients.\nPan-India Distribution – Easy availability across pharmacies and hospitals.\nPatient-Centric Approach – Focused on improving patient outcomes and quality of life.\nSteris Healthcare ensures that Pyritigmin Riva 3 (Rivastigmine Capsules IP 3 mg) is a reliable, safe, and effective solution for managing dementia-related symptoms.", "price": 250.0, "discountamount": 175.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2177, "imageuri": "https://productimages.withfloats.com/actual/68beb3505b1b9933009f8517.png", "tileimageuri": "https://productimages.withfloats.com/tile/68beb3505b1b9933009f8517.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-08T10:43:21.61Z", "updatedon": "2025-09-08T10:43:21.61Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rivastigmine-capsules-ip-3-mg/2177", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PYRITIGMIN RIVA 3", "category": "NEUROLOGY RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68bc22e83c3803d861d696a9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CEPHODOXIAA 200", "description": "CEPHODOXIAA 200 is a broad-spectrum oral antibiotic from Steris Healthcare Pvt. Ltd., containing Cefpodoxime Proxetil 200 mg. It belongs to the third-generation cephalosporin class, designed to combat a wide range of bacterial infections effectively. With its high bioavailability, safety profile, and proven efficacy, it is trusted in clinical practice for managing both respiratory and urinary tract infections.\n\nUsage and Benefits\nCEPHODOXIAA 200 is prescribed for the treatment of bacterial infections caused by susceptible microorganisms, including:\n\nRespiratory tract infections (bronchitis, pneumonia, sinusitis, pharyngitis, tonsillitis)\n\nUrinary tract infections (cystitis, pyelonephritis)\n\nEar infections (otitis media)\n\nSkin and soft tissue infections\n\nCertain sexually transmitted infections (like gonorrhea)\n\nCommunity-acquired infections where cephalosporins are indicated\n\nBenefits:\n\nBroad-spectrum antibacterial activity against gram-positive and gram-negative organisms\n\nHigh tolerability and oral bioavailability\n\nConvenient twice-daily dosing\n\nEffective alternative when resistance to other antibiotics is suspected\n\nDosage and Administration\nAdults: Typical dose is 200 mg every 12 hours, depending on the severity of the infection.\n\nChildren: Dose is weight-adjusted, usually prescribed in suspension form.\n\nDuration: Treatment typically lasts 5–14 days depending on the infection type and clinical response.\n\nAdministration Tips:\n\nTake with food to enhance absorption.\n\nComplete the full course even if symptoms improve early.\n\nDo not double the dose if a dose is missed—take it as soon as remembered unless it is nearly time for the next dose.\n\nSide Effects\nLike all medicines, CEPHODOXIAA 200 may cause mild to moderate side effects. Common ones include:\n\nGastrointestinal upset (nausea, diarrhea, abdominal pain)\n\nHeadache or dizziness\n\nSkin rash or itching\n\nRare but serious side effects:\n\nSevere allergic reactions (swelling, difficulty breathing)\n\nPseudomembranous colitis (persistent diarrhea)\n\nLiver enzyme elevations\n\nDrug Interactions\nAntacids & H2 blockers: May reduce absorption of Cefpodoxime. Take at least 2–3 hours apart.\n\nBlood thinners (e.g., warfarin): May increase risk of bleeding.\n\nOther antibiotics: Avoid concurrent use unless directed by a doctor to prevent resistance.\n\nAlways inform your physician of all medications and supplements you are taking before starting therapy.\n\nConclusion\nCEPHODOXIAA 200 (Cefpodoxime Proxetil 200 mg) from Steris Healthcare Pvt. Ltd. is a reliable, broad-spectrum antibiotic used in the management of common bacterial infections. With its excellent safety profile, ease of oral administration, and clinical efficacy, it remains a preferred choice for doctors worldwide. Patients should adhere strictly to prescribed dosage and complete the treatment course to ensure optimal results and prevent antibiotic resistance.", "price": 185.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2173, "imageuri": "https://productimages.withfloats.com/actual/68bc22f9fc1a4c6e66f328c5.png", "tileimageuri": "https://productimages.withfloats.com/tile/68bc22f9fc1a4c6e66f328c5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-06T12:02:48.098Z", "updatedon": "2025-09-08T10:03:20.923Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cephodoxiaa-200/2173", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cefpodoxime Proxetil Tablets IP 200 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }